Oppenheimer Asset Management Inc. lifted its position in Steris Plc (NYSE:STE) by 1.3% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 19,439 shares of the medical equipment provider’s stock after purchasing an additional 254 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Steris Plc were worth $1,585,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently made changes to their positions in STE. Russell Investments Group Ltd. grew its holdings in shares of Steris Plc by 57.5% in the first quarter. Russell Investments Group Ltd. now owns 132,035 shares of the medical equipment provider’s stock valued at $9,171,000 after purchasing an additional 48,188 shares during the period. Oregon Public Employees Retirement Fund grew its holdings in shares of Steris Plc by 1.3% in the first quarter. Oregon Public Employees Retirement Fund now owns 30,160 shares of the medical equipment provider’s stock valued at $2,095,000 after purchasing an additional 400 shares during the period. Canada Pension Plan Investment Board grew its holdings in shares of Steris Plc by 112.8% in the first quarter. Canada Pension Plan Investment Board now owns 38,100 shares of the medical equipment provider’s stock valued at $2,646,000 after purchasing an additional 20,200 shares during the period. Great West Life Assurance Co. Can grew its holdings in shares of Steris Plc by 6.4% in the first quarter. Great West Life Assurance Co. Can now owns 129,784 shares of the medical equipment provider’s stock valued at $9,021,000 after purchasing an additional 7,839 shares during the period. Finally, State Treasurer State of Michigan grew its holdings in shares of Steris Plc by 0.6% in the first quarter. State Treasurer State of Michigan now owns 34,500 shares of the medical equipment provider’s stock valued at $2,396,000 after purchasing an additional 200 shares during the period. 93.33% of the stock is owned by hedge funds and other institutional investors.
In other news, Director Michael B. Wood sold 4,000 shares of the business’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $81.50, for a total transaction of $326,000.00. Following the completion of the sale, the director now owns 26,131 shares in the company, valued at approximately $2,129,676.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total value of $856,900.00. Following the sale, the chief executive officer now owns 83,270 shares of the company’s stock, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Insiders have sold a total of 176,086 shares of company stock valued at $15,297,621 in the last quarter. Company insiders own 2.55% of the company’s stock.
STE has been the subject of a number of analyst reports. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a research note on Tuesday, July 11th. Wellington Shields lowered shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a research note on Monday, June 5th. Finally, Raymond James Financial, Inc. increased their target price on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 9th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $86.75.
TRADEMARK VIOLATION NOTICE: This news story was originally posted by BBNS and is owned by of BBNS. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://baseballnewssource.com/markets/oppenheimer-asset-management-inc-acquires-254-shares-of-steris-plc-ste/1602035.html.
Steris Plc (NYSE:STE) opened at 87.04 on Friday. Steris Plc has a 52 week low of $63.80 and a 52 week high of $88.11. The firm’s 50-day moving average is $85.66 and its 200 day moving average is $78.30. The stock has a market cap of $7.42 billion, a price-to-earnings ratio of 62.26 and a beta of 1.29.
Steris Plc (NYSE:STE) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the consensus estimate of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The company had revenue of $608.00 million during the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter in the previous year, the business earned $0.79 EPS. The firm’s revenue was down 4.8% on a year-over-year basis. On average, equities research analysts expect that Steris Plc will post $4.06 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.31 per share. The ex-dividend date is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.42%. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s payout ratio is presently 88.57%.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with our FREE daily email newsletter.